Literature DB >> 7290776

Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants.

P M Blum, D L Phelps, B J Ank, H J Krantman, E R Stiehm.   

Abstract

Six immature infants were given oral feedings of 10% preservative-free human immune serum globulin ranging from 1 to 8 ml/kg/day. A seventh infant served as a control. Undigested and partially digested IgG was detected in the stools in significant quantities in all but the control infant. This coproantibody retained significant opsonic activity for type III group B streptococci as determined by a chemiluminescence assay, but lost most of its tetanus antibody activity. The newborn infants' enzymatic immaturity or rapid transit time permits the passage of intact IgG or partially digested IgG to pass throughout the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7290776     DOI: 10.1203/00006450-198109000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 2.  Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants.

Authors:  Mohan Pammi; Khalid N Haque
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

3.  Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells.

Authors:  E J Israel; S Taylor; Z Wu; E Mizoguchi; R S Blumberg; A Bhan; N E Simister
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 4.  Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections.

Authors:  D Carlander; H Kollberg; P E Wejåker; A Larsson
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora.

Authors:  A K Bogstedt; C E Nord; L Hammarström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

Review 6.  Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.

Authors:  Mohan Pammi; Khalid N Haque
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 7.  Oral delivery of antibodies. Future pharmacokinetic trends.

Authors:  R M Reilly; R Domingo; J Sandhu
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

8.  Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model.

Authors:  M Santhanakrishnan; C A Tormey; P Natarajan; J Liu; J E Hendrickson
Journal:  Vox Sang       Date:  2016-03-07       Impact factor: 2.144

Review 9.  The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?

Authors:  Barrett W Newsome; Marc S Ernstoff
Journal:  Br J Clin Pharmacol       Date:  2008-05-22       Impact factor: 4.335

10.  Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis.

Authors:  G A Losonsky; J P Johnson; J A Winkelstein; R H Yolken
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.